;

Home >>

Global CancerTumor Profiling Market Report 2020 by Key Players Types Applications Countries Market Size Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

Published: Sep-2020 | Format: PDF | Maia Research | Number of pages: 107 | Code: MRS - 772983

The Cancer/Tumor Profiling market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Cancer/Tumor Profiling market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Cancer/Tumor Profiling market. The report focuses on well-known providers in the global Cancer/Tumor Profiling industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Cancer/Tumor Profiling Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Cancer/Tumor Profiling market covered in Chapter 4:
Illumina Inc. (U.S.)
HTG Molecular Diagnostic (U.S.)
Genomic Health Inc. (U.S.)
NeoGenomics Laboratories (U.S.)
QIAGEN N.V. (Netherlands)

In Chapter 11 and 13.3, on the basis of types, the Cancer/Tumor Profiling market from 2015 to 2026 is primarily split into:
Next-generation Sequencing
In Situ Hybridization
Immunohistochemistry
Quantitative PCR

In Chapter 12 and 13.4, on the basis of applications, the Cancer/Tumor Profiling market from 2015 to 2026 covers:
Personalized Medicine
Biomarker Discovery
Diagnostics
Prognostics

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2026
Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Cancer/Tumor Profiling Market Share by Type (2020-2026)
1.5.2 Next-generation Sequencing
1.5.3 In Situ Hybridization
1.5.4 Immunohistochemistry
1.5.5 Quantitative PCR
1.6 Market by Application
1.6.1 Global Cancer/Tumor Profiling Market Share by Application (2020-2026)
1.6.2 Personalized Medicine
1.6.3 Biomarker Discovery
1.6.4 Diagnostics
1.6.5 Prognostics
1.7 Cancer/Tumor Profiling Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Cancer/Tumor Profiling Industry Development

2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19

3 Value Chain of Cancer/Tumor Profiling Market
3.1 Value Chain Status
3.2 Cancer/Tumor Profiling Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Cancer/Tumor Profiling
3.2.3 Labor Cost of Cancer/Tumor Profiling
3.2.3.1 Labor Cost of Cancer/Tumor Profiling Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19

4 Players Profiles
4.1 Illumina Inc. (U.S.)
4.1.1 Illumina Inc. (U.S.) Basic Information
4.1.2 Cancer/Tumor Profiling Product Profiles, Application and Specification
4.1.3 Illumina Inc. (U.S.) Cancer/Tumor Profiling Market Performance (2015-2020)
4.1.4 Illumina Inc. (U.S.) Business Overview
4.2 HTG Molecular Diagnostic (U.S.)
4.2.1 HTG Molecular Diagnostic (U.S.) Basic Information
4.2.2 Cancer/Tumor Profiling Product Profiles, Application and Specification
4.2.3 HTG Molecular Diagnostic (U.S.) Cancer/Tumor Profiling Market Performance (2015-2020)
4.2.4 HTG Molecular Diagnostic (U.S.) Business Overview
4.3 Genomic Health Inc. (U.S.)
4.3.1 Genomic Health Inc. (U.S.) Basic Information
4.3.2 Cancer/Tumor Profiling Product Profiles, Application and Specification
4.3.3 Genomic Health Inc. (U.S.) Cancer/Tumor Profiling Market Performance (2015-2020)
4.3.4 Genomic Health Inc. (U.S.) Business Overview
4.4 NeoGenomics Laboratories (U.S.)
4.4.1 NeoGenomics Laboratories (U.S.) Basic Information
4.4.2 Cancer/Tumor Profiling Product Profiles, Application and Specification
4.4.3 NeoGenomics Laboratories (U.S.) Cancer/Tumor Profiling Market Performance (2015-2020)
4.4.4 NeoGenomics Laboratories (U.S.) Business Overview
4.5 QIAGEN N.V. (Netherlands)
4.5.1 QIAGEN N.V. (Netherlands) Basic Information
4.5.2 Cancer/Tumor Profiling Product Profiles, Application and Specification
4.5.3 QIAGEN N.V. (Netherlands) Cancer/Tumor Profiling Market Performance (2015-2020)
4.5.4 QIAGEN N.V. (Netherlands) Business Overview

5 Global Cancer/Tumor Profiling Market Analysis by Regions
5.1 Global Cancer/Tumor Profiling Sales, Revenue and Market Share by Regions
5.1.1 Global Cancer/Tumor Profiling Sales by Regions (2015-2020)
5.1.2 Global Cancer/Tumor Profiling Revenue by Regions (2015-2020)
5.2 North America Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
5.3 Europe Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
5.4 Asia-Pacific Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
5.5 Middle East and Africa Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
5.6 South America Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)

6 North America Cancer/Tumor Profiling Market Analysis by Countries
6.1 North America Cancer/Tumor Profiling Sales, Revenue and Market Share by Countries
6.1.1 North America Cancer/Tumor Profiling Sales by Countries (2015-2020)
6.1.2 North America Cancer/Tumor Profiling Revenue by Countries (2015-2020)
6.1.3 North America Cancer/Tumor Profiling Market Under COVID-19
6.2 United States Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
6.2.1 United States Cancer/Tumor Profiling Market Under COVID-19
6.3 Canada Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
6.4 Mexico Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)

7 Europe Cancer/Tumor Profiling Market Analysis by Countries
7.1 Europe Cancer/Tumor Profiling Sales, Revenue and Market Share by Countries
7.1.1 Europe Cancer/Tumor Profiling Sales by Countries (2015-2020)
7.1.2 Europe Cancer/Tumor Profiling Revenue by Countries (2015-2020)
7.1.3 Europe Cancer/Tumor Profiling Market Under COVID-19
7.2 Germany Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
7.2.1 Germany Cancer/Tumor Profiling Market Under COVID-19
7.3 UK Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
7.3.1 UK Cancer/Tumor Profiling Market Under COVID-19
7.4 France Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
7.4.1 France Cancer/Tumor Profiling Market Under COVID-19
7.5 Italy Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
7.5.1 Italy Cancer/Tumor Profiling Market Under COVID-19
7.6 Spain Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
7.6.1 Spain Cancer/Tumor Profiling Market Under COVID-19
7.7 Russia Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
7.7.1 Russia Cancer/Tumor Profiling Market Under COVID-19

8 Asia-Pacific Cancer/Tumor Profiling Market Analysis by Countries
8.1 Asia-Pacific Cancer/Tumor Profiling Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Cancer/Tumor Profiling Sales by Countries (2015-2020)
8.1.2 Asia-Pacific Cancer/Tumor Profiling Revenue by Countries (2015-2020)
8.1.3 Asia-Pacific Cancer/Tumor Profiling Market Under COVID-19
8.2 China Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
8.2.1 China Cancer/Tumor Profiling Market Under COVID-19
8.3 Japan Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
8.3.1 Japan Cancer/Tumor Profiling Market Under COVID-19
8.4 South Korea Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
8.4.1 South Korea Cancer/Tumor Profiling Market Under COVID-19
8.5 Australia Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
8.6 India Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
8.6.1 India Cancer/Tumor Profiling Market Under COVID-19
8.7 Southeast Asia Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
8.7.1 Southeast Asia Cancer/Tumor Profiling Market Under COVID-19

9 Middle East and Africa Cancer/Tumor Profiling Market Analysis by Countries
9.1 Middle East and Africa Cancer/Tumor Profiling Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cancer/Tumor Profiling Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Cancer/Tumor Profiling Revenue by Countries (2015-2020)
9.1.3 Middle East and Africa Cancer/Tumor Profiling Market Under COVID-19
9.2 Saudi Arabia Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
9.3 UAE Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
9.4 Egypt Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
9.5 Nigeria Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
9.6 South Africa Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)

10 South America Cancer/Tumor Profiling Market Analysis by Countries
10.1 South America Cancer/Tumor Profiling Sales, Revenue and Market Share by Countries
10.1.1 South America Cancer/Tumor Profiling Sales by Countries (2015-2020)
10.1.2 South America Cancer/Tumor Profiling Revenue by Countries (2015-2020)
10.1.3 South America Cancer/Tumor Profiling Market Under COVID-19
10.2 Brazil Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
10.2.1 Brazil Cancer/Tumor Profiling Market Under COVID-19
10.3 Argentina Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
10.4 Columbia Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)
10.5 Chile Cancer/Tumor Profiling Sales and Growth Rate (2015-2020)

11 Global Cancer/Tumor Profiling Market Segment by Types
11.1 Global Cancer/Tumor Profiling Sales, Revenue and Market Share by Types (2015-2020)
11.1.1 Global Cancer/Tumor Profiling Sales and Market Share by Types (2015-2020)
11.1.2 Global Cancer/Tumor Profiling Revenue and Market Share by Types (2015-2020)
11.2 Next-generation Sequencing Sales and Price (2015-2020)
11.3 In Situ Hybridization Sales and Price (2015-2020)
11.4 Immunohistochemistry Sales and Price (2015-2020)
11.5 Quantitative PCR Sales and Price (2015-2020)

12 Global Cancer/Tumor Profiling Market Segment by Applications
12.1 Global Cancer/Tumor Profiling Sales, Revenue and Market Share by Applications (2015-2020)
12.1.1 Global Cancer/Tumor Profiling Sales and Market Share by Applications (2015-2020)
12.1.2 Global Cancer/Tumor Profiling Revenue and Market Share by Applications (2015-2020)
12.2 Personalized Medicine Sales, Revenue and Growth Rate (2015-2020)
12.3 Biomarker Discovery Sales, Revenue and Growth Rate (2015-2020)
12.4 Diagnostics Sales, Revenue and Growth Rate (2015-2020)
12.5 Prognostics Sales, Revenue and Growth Rate (2015-2020)

13 Cancer/Tumor Profiling Market Forecast by Regions (2020-2026)
13.1 Global Cancer/Tumor Profiling Sales, Revenue and Growth Rate (2020-2026)
13.2 Cancer/Tumor Profiling Market Forecast by Regions (2020-2026)
13.2.1 North America Cancer/Tumor Profiling Market Forecast (2020-2026)
13.2.2 Europe Cancer/Tumor Profiling Market Forecast (2020-2026)
13.2.3 Asia-Pacific Cancer/Tumor Profiling Market Forecast (2020-2026)
13.2.4 Middle East and Africa Cancer/Tumor Profiling Market Forecast (2020-2026)
13.2.5 South America Cancer/Tumor Profiling Market Forecast (2020-2026)
13.3 Cancer/Tumor Profiling Market Forecast by Types (2020-2026)
13.4 Cancer/Tumor Profiling Market Forecast by Applications (2020-2026)
13.5 Cancer/Tumor Profiling Market Forecast Under COVID-19

14 Appendix
14.1 Methodology
14.2 Research Data Source


                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)3400 View Pricing